{"id":"clm_5CC511D1F933","entity":"regeneron-pharmaceuticals","predicate":"cash_and_equivalents","value":"2,506,400,000 United States dollar","value_json":{"fp":"Q3","fy":2025,"accn":"0000872589-25-000028","form":"10-Q","filed":"2025-10-28","period":"Q3 FY2025","concept":"us-gaap:CashAndCashEquivalentsAtCarryingValue"},"valid_from":"2025-09-30","valid_to":"2025-12-31","published":"2025-10-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Regeneron Pharmaceuticals cash and equivalents: 2,506,400,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_5CC511D1F933, https://asof.is/claim/clm_5CC511D1F933, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000087258925000028/0000872589-25-000028-index.htm.","url":"https://asof.is/claim/clm_5CC511D1F933","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B18C1963BC40","supersedes":["clm_436CC0AE1280"],"first_seen_at":"2026-11-08T17:08:55.512322+00:00","updated_at":"2026-11-08T17:09:02.679946+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/872589/000087258925000028/0000872589-25-000028-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2025, filed 2025-10-28"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}